R Swaminathan1. 1. Department of Chemical Pathology, Guy's, King's and St. Thomas' School of Medicine, St. Thomas' Campus, Lambeth Palace Road, SE1 7EH, London, UK. r.swaminathan@kcl.ac.uk
Abstract
BACKGROUND: Osteoporosis in many countries has reached epidemic proportions. This has stimulated the development of biochemical markers to assist in the assessment of osteoporotic risk and in monitoring the efficacy of treatment. Biochemical markers of bone turnover are products released from osteoblasts and osteoclasts or collagen breakdown products. MARKERS: Markers of bone formation include bone-specific alkaline phosphatase (BAP), osteocalcin (OC) and procollagen peptides. All of these can be measured easily by immunoassay techniques. Of these markers, OC has been extensively studied. However, OC undergoes in vitro degradation, thus, assay results are variable. BAP, on the other hand, is much more stable and shows less within-person biological variation. Bone resorption markers include tartrate-resistant acid phosphatase (TRAP) and collagen breakdown products, such as pyridinium cross-links, galactosyl hydroxylysine and cross-linked telopeptides, such as CTx and NTx. Of these, deoxypyridinium (DPD) has been extensively studied. DPD shows diurnal variation and the within-individual biological variation is large. Of the newer assays, NTx appear to show large differences at menopause. CONCLUSIONS: Thus, serum BAP and DPD or NTx are the current choice of bone markers.
BACKGROUND:Osteoporosis in many countries has reached epidemic proportions. This has stimulated the development of biochemical markers to assist in the assessment of osteoporotic risk and in monitoring the efficacy of treatment. Biochemical markers of bone turnover are products released from osteoblasts and osteoclasts or collagen breakdown products. MARKERS: Markers of bone formation include bone-specific alkaline phosphatase (BAP), osteocalcin (OC) and procollagen peptides. All of these can be measured easily by immunoassay techniques. Of these markers, OC has been extensively studied. However, OC undergoes in vitro degradation, thus, assay results are variable. BAP, on the other hand, is much more stable and shows less within-person biological variation. Bone resorption markers include tartrate-resistant acid phosphatase (TRAP) and collagen breakdown products, such as pyridinium cross-links, galactosyl hydroxylysine and cross-linked telopeptides, such as CTx and NTx. Of these, deoxypyridinium (DPD) has been extensively studied. DPD shows diurnal variation and the within-individual biological variation is large. Of the newer assays, NTx appear to show large differences at menopause. CONCLUSIONS: Thus, serum BAP and DPD or NTx are the current choice of bone markers.
Authors: C E Neville; I S Young; S E C M Gilchrist; M C McKinley; A Gibson; J D Edgar; J V Woodside Journal: Osteoporos Int Date: 2013-05-29 Impact factor: 4.507
Authors: A Noorafshan; M H Dabbaghmanesh; N Tanideh; F Koohpeyma; R Rasooli; M Hajihoseini; M Bakhshayeshkaram; O K Hosseinabadi Journal: Osteoporos Int Date: 2015-07-15 Impact factor: 4.507
Authors: Adetunji T Toriola; Jingxia Liu; Patricia A Ganz; Graham A Colditz; Lin Yang; Sonya Izadi; Michael J Naughton; Anna L Schwartz; Kathleen Y Wolin Journal: Breast Cancer Res Treat Date: 2015-07-15 Impact factor: 4.872
Authors: Ryan D Ross; Raj C Shah; Sue Leurgans; Teodoro Bottiglieri; Robert S Wilson; Dale Rick Sumner Journal: J Gerontol A Biol Sci Med Sci Date: 2018-11-10 Impact factor: 6.053
Authors: Amadeus C S de Alcântara; Israel Assis; Daniel Prada; Konrad Mehle; Stefan Schwan; Lucia Costa-Paiva; Munir S Skaf; Luiz C Wrobel; Paulo Sollero Journal: Materials (Basel) Date: 2019-12-24 Impact factor: 3.623